P

Inventor

JAKOBOVITS AYA

US188 patents
⚠️ This page may combine multiple inventors who share the name “JAKOBOVITS AYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AGENSYS INC

26 patents
US7507541B2Mar 24, 2009

36P6D5: secreted tumor antigen

AGENSYS INC89 citations98
US7494646B2Feb 24, 2009

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

AGENSYS INC38 citations96
US7361338B2Apr 22, 2008

Methods to inhibit growth of prostate cancer cells

AGENSYS INC40 citations96
US7226594B2Jun 5, 2007

Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer

AGENSYS INC25 citations96
US8013128B2Sep 6, 2011

Antibodies and related molecules that bind to PSCA proteins

AGENSYS INC28 citations93
US7968090B2Jun 28, 2011

Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer

AGENSYS INC19 citations93
US7884179B2Feb 8, 2011

Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer

AGENSYS INC20 citations93
US7667018B2Feb 23, 2010

Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer

AGENSYS INC10 citations93
US7641905B2Jan 5, 2010

Methods of inducing an immune response

AGENSYS INC25 citations93
US7628989B2Dec 8, 2009

Methods of inducing an immune response

AGENSYS INC23 citations93
US7622564B2Nov 24, 2009

Prostate stem cell antigen (PSCA) variants and subsequences thereof

AGENSYS INC20 citations93
US7595379B2Sep 29, 2009

Antibodies and related molecules that bind to PSCA proteins

AGENSYS INC34 citations93
US7541442B2Jun 2, 2009

Antibodies and related molecules that bind to PSCA proteins

AGENSYS INC26 citations93
US7405290B2Jul 29, 2008

Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer

AGENSYS INC23 citations93
US7244827B2Jul 17, 2007

Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer

AGENSYS INC20 citations93
US7067130B2Jun 27, 2006

Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer

AGENSYS INC27 citations93
US6602501B1Aug 5, 2003

C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof

AGENSYS INC13 citations93
US9314538B2Apr 19, 2016

Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins

AGENSYS INC9 citations92
US9078931B2Jul 14, 2015

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

AGENSYS INC11 citations92
US8013135B2Sep 6, 2011

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

AGENSYS INC16 citations92
US8008442B2Aug 30, 2011

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

AGENSYS INC22 citations92
US7947459B2May 24, 2011

Serpentine transmembrane antigens expressed in human cancers and uses thereof

AGENSYS INC19 citations92
US7939503B2May 10, 2011

Reduction of cell-cell communication in prostate cancer using STEAP-1 siRNA

AGENSYS INC17 citations92
US7811565B2Oct 12, 2010

Antibodies and related molecules that bind to 161P2F10B proteins

AGENSYS INC20 citations92
US7510840B1Mar 31, 2009

Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody

AGENSYS INC16 citations92
US7459539B2Dec 2, 2008

Antibody that binds zinc transporter protein 108P5H8

AGENSYS INC16 citations92

ABGENIX INC

15 patents
US6673986B1Jan 6, 2004

Generation of xenogeneic antibodies

ABGENIX INC478 citations99
US6657103B1Dec 2, 2003

Human antibodies derived from immunized xenomice

ABGENIX INC260 citations99
US6458592B1Oct 1, 2002

Production of antibodies using cre-mediated site-specific recombination

ABGENIX INC126 citations99
US6235883B1May 22, 2001

Human monoclonal antibodies to epidermal growth factor receptor

ABGENIX INC831 citations99
US6162963ADec 19, 2000

Generation of Xenogenetic antibodies

ABGENIX INC1,334 citations99
US6150584ANov 21, 2000

Human antibodies derived from immunized xenomice

ABGENIX INC3,069 citations99
US6130364AOct 10, 2000

Production of antibodies using Cre-mediated site-specific recombination

ABGENIX INC521 citations99
US6091001AJul 18, 2000

Production of antibodies using Cre-mediated site-specific recombination

ABGENIX INC502 citations99
US6075181AJun 13, 2000

Human antibodies derived from immunized xenomice

ABGENIX INC3,137 citations99
US5939598AAug 17, 1999

Method of making transgenic mice lacking endogenous heavy chains

ABGENIX INC2,618 citations99
US5985615ANov 16, 1999

Directed switch-mediated DNA recombination

ABGENIX INC346 citations98
US5916771AJun 29, 1999

Production of a multimeric protein by cell fusion method

ABGENIX INC1,034 citations98
US7064244B2Jun 20, 2006

Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom

ABGENIX INC197 citations97
US6207418B1Mar 27, 2001

Production of a multimeric protein by cell fusion method

ABGENIX INC86 citations97
US6114598ASep 5, 2000

Generation of xenogeneic antibodies

ABGENIX INC1,486 citations97

UNIV CALIFORNIA

3 patents

JAPAN TOBACCO INC

1 patent

(unassigned)

1 patent

CELL GENESYS INC

1 patent

RAITANO ARTHUR B

1 patent

GUDAS JEAN

1 patent

AMGEN FREMONT INC

1 patent

Showing the top 50 of 188 patents by PatentIndex Score.